Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma
Melanie Werner‐Klein(University Hospital Regensburg), Christoph A. Klein(Fraunhofer Institute for Toxicology and Experimental Medicine)
Cited by 89
Related Papers
Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients
|EMBO Molecular Medicine|2025|1
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0